The TRICURE US IDE Pivotal Study
NCT: NCT07528326 · NOT_YET_RECRUITING
NCT IDNCT07528326
StatusNOT_YET_RECRUITING
Start Date2026-10
Completion2035-09
Brief Summary
The purpose of the study is to evaluate safety and effectiveness of the TRiCares Topaz TTVR system for treatment of subjects presenting with clinically relevant tricuspid regurgitation who are suitable for valve replacement.
Frequently Asked Questions
What is The TRICURE US IDE Pivotal Study?
The TRICURE US IDE Pivotal Study is a clinical trial registered under NCT07528326. Current status: NOT_YET_RECRUITING.
What is the status of NCT07528326?
The current status of NCT07528326 (The TRICURE US IDE Pivotal Study) is: NOT_YET_RECRUITING.
When did The TRICURE US IDE Pivotal Study start?
The TRICURE US IDE Pivotal Study started on 2026-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.